Marie Castets

Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Correction: Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors.

Correction: Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors.

Journal: Chemical science

Published: June 10, 2026

Diffuse midline gliomas and H3.3K27M mutation: How does BMP2/7 signaling shape the emergence of a quiescent and invasive cellular state?

Diffuse midline gliomas and H3.3K27M mutation: How does BMP2/7 signaling shape the emergence of a quiescent and invasive cellular state?

Journal: Medecine sciences : M/S

Published: February 24, 2026

The Goldilocks paradox: when partial oncoprotein inhibition fuels metastasis in Ewing sarcoma.

The Goldilocks paradox: when partial oncoprotein inhibition fuels metastasis in Ewing sarcoma.

Journal: EMBO molecular medicine

Published: December 03, 2025

Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology.

Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology.

Journal: Neuro-oncology

Published: January 10, 2025

ERO1a fosters glioblastoma aggressiveness and metabolic flexibility by regulating mitochondria-associated membrane dynamics.

ERO1a fosters glioblastoma aggressiveness and metabolic flexibility by regulating mitochondria-associated membrane dynamics.

Journal: Nature cell biology

Published: December 12, 2024

BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas.

BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas.

Journal: eLife

Published: October 07, 2024

Anti-IL-6R Ab tocilizumab to treat paraneoplastic inflammatory syndrome of solid cancers.

Anti-IL-6R Ab tocilizumab to treat paraneoplastic inflammatory syndrome of solid cancers.

Journal: ESMO open

Published: September 19, 2024

Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?

Bone Morphogenic Proteins in Pediatric Diffuse Midline Gliomas: How to Make New Out of Old?

Journal: International journal of molecular sciences

Published: January 08, 2024

A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity.

A novel inhibitor of the mitochondrial respiratory complex I with uncoupling properties exerts potent antitumor activity.

Journal: Cell death & disease

Published: July 06, 2023

Preventable cancers: Is it enough to change our behaviour?

Preventable cancers: Is it enough to change our behaviour?

Journal: Medecine sciences : M/S

Published: May 23, 2023

Holistic pediatric oncology: towards a second Copernican revolution.

Holistic pediatric oncology: towards a second Copernican revolution.

Journal: Trends in cancer

Published: April 17, 2023

Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.

Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.

Journal: Cell reports. Medicine

Published: April 13, 2023

Showing 1-12 of 29

Last Updated: 09/26/2026